28355176|t|Visualization and targeting of LGR5(+) human colon cancer stem cells
28355176|a|The cancer stem cell (CSC) theory highlights a self-renewing subpopulation of cancer cells that fuels tumour growth. The existence of human CSCs is mainly supported by xenotransplantation of prospectively isolated cells, but their clonal dynamics and plasticity remain unclear. Here, we show that human LGR5(+) colorectal cancer cells serve as CSCs in growing cancer tissues. Lineage - tracing experiments with a tamoxifen -inducible Cre knock-in allele of LGR5 reveal the self-renewal and differentiation capacity of LGR5(+) tumour cells. Selective ablation of LGR5(+) CSCs in LGR5 -i Caspase9 knock-in organoids leads to tumour regression, followed by tumour regrowth driven by re-emerging LGR5(+) CSCs. KRT20 knock-in reporter marks differentiated cancer cells that constantly diminish in tumour tissues, while reverting to LGR5(+) CSCs and contributing to tumour regrowth after LGR5(+) CSC ablation. We also show that combined chemotherapy potentiates targeting of LGR5(+) CSCs. These data provide insights into the plasticity of CSCs and their potential as a therapeutic target in human colorectal cancer.
28355176	0	13	Visualization	T033	UMLS:C0243095
28355176	31	38	LGR5(+)	T017	UMLS:C1537570
28355176	39	44	human	T204	UMLS:C0086418
28355176	45	50	colon	T017	UMLS:C0009368
28355176	51	68	cancer stem cells	T017	UMLS:C1956422
28355176	73	89	cancer stem cell	T017	UMLS:C1956422
28355176	91	94	CSC	T017	UMLS:C1956422
28355176	116	129	self-renewing	T038	UMLS:C4042950
28355176	130	143	subpopulation	T170	UMLS:C0449560
28355176	147	159	cancer cells	T017	UMLS:C0334227
28355176	203	208	human	T204	UMLS:C0086418
28355176	209	213	CSCs	T017	UMLS:C1956422
28355176	237	256	xenotransplantation	T058	UMLS:C0520484
28355176	274	288	isolated cells	T033	UMLS:C3829491
28355176	300	306	clonal	T017	UMLS:C1522642
28355176	366	371	human	T204	UMLS:C0086418
28355176	372	379	LGR5(+)	T017	UMLS:C1537570
28355176	380	403	colorectal cancer cells	T017	UMLS:C0334227
28355176	413	417	CSCs	T017	UMLS:C1956422
28355176	429	435	cancer	T038	UMLS:C0006826
28355176	436	443	tissues	T017	UMLS:C0040300
28355176	455	474	tracing experiments	T058	UMLS:C0022885
28355176	482	491	tamoxifen	T103	UMLS:C0039286
28355176	503	506	Cre	T103	UMLS:C1744318
28355176	507	515	knock-in	T062	UMLS:C2350597
28355176	516	522	allele	T017	UMLS:C0002085
28355176	526	530	LGR5	T103	UMLS:C3640115
28355176	542	554	self-renewal	T038	UMLS:C4042950
28355176	559	574	differentiation	T038	UMLS:C0007589
28355176	587	594	LGR5(+)	T017	UMLS:C1537570
28355176	595	607	tumour cells	T017	UMLS:C0334227
28355176	619	627	ablation	T058	UMLS:C0547070
28355176	631	638	LGR5(+)	T017	UMLS:C1537570
28355176	639	643	CSCs	T017	UMLS:C1956422
28355176	647	651	LGR5	T017	UMLS:C1537570
28355176	655	663	Caspase9	T017	UMLS:C1332668
28355176	664	672	knock-in	T062	UMLS:C2350597
28355176	673	682	organoids	T017	UMLS:C0029250
28355176	761	768	LGR5(+)	T017	UMLS:C1537570
28355176	769	773	CSCs	T017	UMLS:C1956422
28355176	775	780	KRT20	T017	UMLS:C1426926
28355176	781	789	knock-in	T062	UMLS:C2350597
28355176	790	798	reporter	T017	UMLS:C0206414
28355176	805	819	differentiated	T038	UMLS:C0007589
28355176	820	832	cancer cells	T017	UMLS:C0334227
28355176	861	875	tumour tissues	T017	UMLS:C0475358
28355176	896	903	LGR5(+)	T017	UMLS:C1537570
28355176	904	908	CSCs	T017	UMLS:C1956422
28355176	951	958	LGR5(+)	T017	UMLS:C1537570
28355176	959	962	CSC	T017	UMLS:C1956422
28355176	963	971	ablation	T058	UMLS:C0547070
28355176	1000	1012	chemotherapy	T058	UMLS:C3665472
28355176	1038	1045	LGR5(+)	T017	UMLS:C1537570
28355176	1046	1050	CSCs	T017	UMLS:C1956422
28355176	1103	1107	CSCs	T017	UMLS:C1956422
28355176	1155	1160	human	T204	UMLS:C0086418
28355176	1161	1178	colorectal cancer	T038	UMLS:C1527249